Teddy Salan 1, Fernando M Moradel Cano2, Denise C Vidot3, Bria-Necole Diggs3, Dario N Ayala2, Sulaiman A Sheriff4, Hanzhi Gao5, Lisa J Reidy6, Eva Widerstrom-Noga7, Suresh Pallikkuth8, Allan E Rodriguez2, Robert L Cook9, Varan Govind1
1Department of Radiology, University of Miami, Miami, United States of America
2Division of Infectious Diseases, Department of Medicine, University of Miami, Miami, United States of America
3School of Nursing and Health Studies, University of Miami, Miami, United States of America
4Department of Radiation Oncology, Henry Ford Health, Detroit, United States of America
5Health Informatics Institute, University of South Florida, Tampa, United States of America
6Department of Pathology and Laboratory Medicine, University of Miami, Miami, United States of America
7The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami, Miami, United States of America
8Department of Microbiology and Immunology, University of Miami, Miami, United States of America
9Department of Epidemiology, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, United States of America
Presenting Author: Teddy Salan
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Mian MN, Sarovar V, Levine T, Lea A, Leibowitz A, Luu M, Flamm J, Hare CB, Horberg M, Young-Wolff KC, Phillips KT, Silverberg MJ, Satre DD. Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care. BMC Public Health. 2025 Jul 29;25(1):2580. doi: 10.1186/s12889-025-23735-8. PMID: 40730987; PMCID: PMC12309092. [doi][pmid]
2. Nath A. Eradication of human immunodeficiency virus from brain reservoirs. J Neurovirol. 2015 Jun;21(3):227-34. doi: 10.1007/s13365-014-0291-1. Epub 2014 Nov 4. PMID: 25366659; PMCID: PMC4418952. [doi][pmid]
4. Kirkland AE, Browning BD, Green R, Agbeh SO, Squeglia LM. Neurometabolite Alterations Associated With Cannabis Use: A Proton Magnetic Resonance Spectroscopy Meta-Analysis. Hum Brain Mapp. 2025 Jun 1;46(8):e70236. doi: 10.1002/hbm.70236. PMID: 40421881; PMCID: PMC12107604. [doi][pmid]
5. Colizzi M, Weltens N, McGuire P, Lythgoe D, Williams S, Van Oudenhove L, Bhattacharyya S. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis. Mol Psychiatry. 2020 Dec;25(12):3231-3240. doi: 10.1038/s41380-019-0374-8. Epub 2019 Feb 15. PMID: 30770892; PMCID: PMC7714685. [doi][pmid]
6. Maudsley AA, et al. Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI). Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine. 2009;61(3):548-559.
7. Maudsley AA, et al. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR in biomedicine. 2006;19(4):492-503.
8. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002 Jan;15(1):273-89.
9. Andrenyak DM, Moody DE, Slawson MH, O'Leary DS, Haney M. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry. J Anal Toxicol. 2017 May 1;41(4):277-288.